These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 26387111)

  • 1. Beta Amyloid Hallmarks: From Intrinsically Disordered Proteins to Alzheimer's Disease.
    Korsak M; Kozyreva T
    Adv Exp Med Biol; 2015; 870():401-21. PubMed ID: 26387111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metal ions and intrinsically disordered proteins and peptides: from Cu/Zn amyloid-β to general principles.
    Faller P; Hureau C; La Penna G
    Acc Chem Res; 2014 Aug; 47(8):2252-9. PubMed ID: 24871565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Fragment-Based Method of Creating Small-Molecule Libraries to Target the Aggregation of Intrinsically Disordered Proteins.
    Joshi P; Chia S; Habchi J; Knowles TP; Dobson CM; Vendruscolo M
    ACS Comb Sci; 2016 Mar; 18(3):144-53. PubMed ID: 26923286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural studies of amyloid-β peptides: Unlocking the mechanism of aggregation and the associated toxicity.
    Aleksis R; Oleskovs F; Jaudzems K; Pahnke J; Biverstål H
    Biochimie; 2017 Sep; 140():176-192. PubMed ID: 28751216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomal cellular prion protein drives fibrillization of amyloid beta and counteracts amyloid beta-mediated neurotoxicity.
    Falker C; Hartmann A; Guett I; Dohler F; Altmeppen H; Betzel C; Schubert R; Thurm D; Wegwitz F; Joshi P; Verderio C; Krasemann S; Glatzel M
    J Neurochem; 2016 Apr; 137(1):88-100. PubMed ID: 26710111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrinsically disordered proteins in various hypotheses on the pathogenesis of Alzheimer's and Parkinson's diseases.
    Coskuner O; Uversky VN
    Prog Mol Biol Transl Sci; 2019; 166():145-223. PubMed ID: 31521231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the p3 Peptide (Aβ17-40, Aβ17-42) Relevant to the Pathology of Alzheimer's Disease?1.
    Kuhn AJ; Raskatov J
    J Alzheimers Dis; 2020; 74(1):43-53. PubMed ID: 32176648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dark side of Alzheimer's disease: unstructured biology of proteins from the amyloid cascade signaling pathway.
    Gadhave K; Gehi BR; Kumar P; Xue B; Uversky VN; Giri R
    Cell Mol Life Sci; 2020 Oct; 77(20):4163-4208. PubMed ID: 31894361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shear-induced amyloid formation of IDPs in the brain.
    Trumbore CN
    Prog Mol Biol Transl Sci; 2019; 166():225-309. PubMed ID: 31521233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic approaches unraveling regulation and aggregation of intrinsically disordered β-amyloids implicated in Alzheimer's disease.
    Kumari A; Rajput R; Shrivastava N; Somvanshi P; Grover A
    Int J Biochem Cell Biol; 2018 Jun; 99():19-27. PubMed ID: 29571707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloids on Membrane Interfaces: Implications for Neurodegeneration.
    Mahakud AK; Shaikh J; Rifa Iqbal VV; Gupta A; Tiwari A; Saleem M
    J Membr Biol; 2022 Dec; 255(6):705-722. PubMed ID: 35670831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Untangling amyloid-β, tau, and metals in Alzheimer's disease.
    Savelieff MG; Lee S; Liu Y; Lim MH
    ACS Chem Biol; 2013 May; 8(5):856-65. PubMed ID: 23506614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of Alzheimer's β-amyloid peptides with cholesterol: mechanistic insights into amyloid pore formation.
    Di Scala C; Chahinian H; Yahi N; Garmy N; Fantini J
    Biochemistry; 2014 Jul; 53(28):4489-502. PubMed ID: 25000142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aβ promotes VDAC1 channel dephosphorylation in neuronal lipid rafts. Relevance to the mechanisms of neurotoxicity in Alzheimer's disease.
    Fernandez-Echevarria C; Díaz M; Ferrer I; Canerina-Amaro A; Marin R
    Neuroscience; 2014 Oct; 278():354-66. PubMed ID: 25168729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
    Matsuzaki K
    Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negatively charged gold nanoparticles inhibit Alzheimer's amyloid-β fibrillization, induce fibril dissociation, and mitigate neurotoxicity.
    Liao YH; Chang YJ; Yoshiike Y; Chang YC; Chen YR
    Small; 2012 Dec; 8(23):3631-9. PubMed ID: 22915547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Small Molecule Stabilizes the Disordered Native State of the Alzheimer's Aβ Peptide.
    Löhr T; Kohlhoff K; Heller GT; Camilloni C; Vendruscolo M
    ACS Chem Neurosci; 2022 Jun; 13(12):1738-1745. PubMed ID: 35649268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aβ propagation and strains: Implications for the phenotypic diversity in Alzheimer's disease.
    Condello C; Stöehr J
    Neurobiol Dis; 2018 Jan; 109(Pt B):191-200. PubMed ID: 28359847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: the emerging role of oligomeric assemblies.
    Kirkitadze MD; Bitan G; Teplow DB
    J Neurosci Res; 2002 Sep; 69(5):567-77. PubMed ID: 12210822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.